Influence of vaginal bacteria and D- and L-lactic acid isomers on vaginal extracellular matrix metalloproteinase inducer: implications for protection against upper genital tract infections

Steven S Witkin, Helena Mendes-Soares, Iara M Linhares, Aswathi Jayaram, William J Ledger, Larry J Forney, Steven S Witkin, Helena Mendes-Soares, Iara M Linhares, Aswathi Jayaram, William J Ledger, Larry J Forney

Abstract

We evaluated levels of vaginal extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase (MMP-8) in vaginal secretions in relation to the composition of vaginal bacterial communities and D- and L-lactic acid levels. The composition of vaginal bacterial communities in 46 women was determined by pyrosequencing the V1 to V3 region of 16S rRNA genes. Lactobacilli were dominant in 71.3% of the women, followed by Gardnerella (17.4%), Streptococcus (8.7%), and Enterococcus (2.2%). Of the lactobacillus-dominated communities, 51.5% were dominated by Lactobacillus crispatus, 36.4% by Lactobacillus iners, and 6.1% each by Lactobacillus gasseri and Lactobacillus jensenii. Concentrations of L-lactic acid were slightly higher in lactobacillus-dominated vaginal samples, but most differences were not statistically significant. D-Lactic acid levels were higher in samples containing L. crispatus than in those with L. iners (P<0.0001) or Gardnerella (P=0.0002). The relative proportion of D-lactic acid in vaginal communities dominated by species of lactobacilli was in concordance with the proportions found in axenic cultures of the various species grown in vitro. Levels of L-lactic acid (P<0.0001) and the ratio of L-lactic acid to D-lactic acid (P=0.0060), but not concentrations of D-lactic acid, were also correlated with EMMPRIN concentrations. Moreover, vaginal concentrations of EMMPRIN and MMP-8 levels were highly correlated (P<0.0001). Taken together, the data suggest the relative proportion of L- to D-lactic acid isomers in the vagina may influence the extent of local EMMPRIN production and subsequent induction of MMP-8. The expression of these proteins may help determine the ability of bacteria to transverse the cervix and initiate upper genital tract infections.

Importance: A large proportion of preterm births (>50%) result from infections caused by bacteria originating in the vagina, which requires that they traverse the cervix. Factors that influence susceptibility to these infections are not well understood; however, there is evidence that matrix metalloproteinase (MMP-8) is known to alter the integrity of the cervix. In this work, we show that concentrations of vaginal extracellular matrix metalloproteinase inducer (EMMPRIN) are influenced by members of the vaginal microbial community and concentrations of D- or L-lactic acid isomers in vaginal secretions. Elevated levels of D-lactic acid and the ratio of D- to L-lactic acid influence EMMPRIN concentrations as well as MMP-8 levels. Thus, isomers of lactic acid may function as signaling molecules that alter host gene expression and influence risk of infection-related preterm birth.

Figures

FIG 1
FIG 1
Association of dominant vaginal bacteria and the ratio of l- to d-lactic acid in vaginal fluid. The composition of vaginal bacterial communities was determined by analysis of 16S rRNA gene sequences. The species of Lactobacillus and other genera present that dominated (constituted the highest proportions) each community was identified. The concentrations of d- and l-lactic acid in each vaginal sample were determined by enzymatic assays. Regression coefficients and P values are reported in the text.
FIG 2
FIG 2
Association of EMMPRIN with d- and l-lactic acid and MMP-8 in vaginal fluid. Vaginal fluids were assayed for EMMPRIN and MMP-8 by ELISA, and d-lactic acid and l-lactic acid were determined by enzymatic assays. Associations between concentrations of EMMPRIN and l-lactic acid (top), d-lactic acid (middle), and MMP-8 (bottom) were analyzed by the Spearman rank correlation test. Regression coefficients and P values are reported in the text.
FIG 3
FIG 3
Concentration of d- and l-lactate produced in axenic cultures of different Lactobacillus species. A value of zero indicates that the isomer was not detected in the samples analyzed.

References

    1. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, Karlebach S, Gorle R, Russell J, Tacket CO, Brotman RM, Davis CC, Ault K, Peralta L, Forney LJ. 2011. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. U. S. A. 108(Suppl 1):4680–4687
    1. Linhares IM, Summers PR, Larsen B, Giraldo PC, Witkin SS. 2011. Contemporary perspectives on vaginal pH and lactobacilli. Am. J. Obstet. Gynecol. 204:e1–e5
    1. Donders G. 2010. Diagnosis and management of bacterial vaginosis and other types of abnormal vaginal bacterial flora: a review. Obstet. Gynecol. Surv. 65:462–473
    1. Donders G, Bellen G, Rezeberga D. 2011. Aerobic vaginitis in pregnancy. BJOG 118:1163–1170
    1. Tamrakar R, Yamada T, Furuta I, Cho K, Morikawa M, Yamada H, Sakuragi N, Minakami H. 2007. Association between lactobacillus species and bacterial vaginosis-related bacteria, and bacterial vaginosis scores in pregnant Japanese women. BMC Infect. Dis. 7:128
    1. Wertz J, Isaacs-Cosgrove N, Holzman C, Marsh TL. 2008. Temporal shifts in microbial communities in nonpregant African-American women with and without bacterial vaginosis. Interdiscip. Perspect. Infect. Dis. 2008:181253 PubMed
    1. Verstraelen H, Verhelst R, Claeys G, De Backer E, Temmerman M, Vaneechoutte M. 2009. Longitudinal analysis of the vaginal microflora in pregnancy suggests that L. crispatus and/or L. iners are more conductive to the occurrence of abnormal vaginal microflora. BMC Microbiol. 9:116
    1. Iacono KT, Brown AL, Greene MI, Saouaf SJ. 2007. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp. Mol. Pathol. 83:283–295
    1. Tang J, Wu YM, Zhao P, Yang XM, Jiang JL, Chen ZN. 2008. Overexpression of HAb18G/CD147 promotes invasion and metastasis via alpha3beta1 integrin mediated FAK-paxillin and FAK-P13K-Ca2+ pathways. Cell. Mol. Life Sci. 65:2933–2942
    1. Braundmeier AG, Fazleabas AT, Lessey BA, Guo H, Toole BP, Nowak RA. 2006. Extracellular matrix metalloproteinase inducer regulates metalloproteinases in human uterine endometrium. J. Clin. Endocrinol. Metab. 91:2358–2365
    1. Rahkonen L, Rutanen EM, Unkila-Kallio L, Nuutila M, Nieminen P, Sorsa T, Paavonen J. 2009. Factors affecting matrix metalloproteinase-8 levels in the vaginal and cervical fluids in the first and second trimester of pregnancy. Hum. Reprod. 24:2693–2702
    1. Wilson MC, Meredth D, Fox JE, Manoharan C, Davies AJ, Halestrap AP. 2005. Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4; the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J. Biol. Chem. 280:27213–27221
    1. Ewaschuk JB, Naylor JM, Zello GA. 2005. d-Lactate in human and ruminant metabolism. J. Nutr. 135:1619–1625
    1. Witkin SS, Alvi S, Bongiovanni AM, Linhares IM, Ledger WJ. 2011. Lactic acid stimulates interleukin-23 production by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide. FEMS Immunol. Med. Microbiol. 61:153–158
    1. Shime H, Yabu M, Akazawa T, Kodama K, Matsumoto M, Seya T, Inoue N. 2008. Tumor-secreted lactic acid promotes IL-23/IL-17 proinflammatory pathway. J. Immunol. 180:7175–7183
    1. Mossop H, Linhares IM, Bongiovanni AM, Ledger WJ, Witkin SS. 2011. Influence of lactic acid on endogenous and viral RNA-induced immune mediator production by vaginal epithelial cells. Obstet. Gynecol. 118:840–846
    1. Végran F, Boidot R, Michiels C, Sonveaux P, Feron O. 2011. Lactate influx through the endothelial cell monocarboxylate transporter MCT-1 supports an NF-κB/IL-8 pathway that drives tumor angiogenesis. Cancer Res. 71:2550–2560
    1. Murray CM, Hutchinson R, Bantick JR, Belfield GP, Benjamin AD, Brazma D, Bundick RV, Cook ID, Craggs RI, Edwards S, Evans LR, Harrison R, Holness E, Jackson AP, Jackson CG, Kingston LP, Perry MW, Ross AR, Rugman PA, Sidhu SS, Sullivan M, Taylor-Fishwick DA, Walker PC, Whitehead YM, Wilkinson DJ, Wright A, Donald DK. 2005. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat. Chem. Biol. 1:371–376
    1. Alakomi HL, Skyttä E, Saarela M, Mattila-Sandholm T, Latva-Kala K, Helander IM. 2000. Lactic acid permeabilizes Gram-negative bacteria by disrupting the outer membrane. Appl. Environ. Microbiol. 66:2001–2005
    1. O’Hanlon DE, Moench TR, Cone RA. 2011. In vaginal fluid, bacteria associated with bacterial vaginosis can be suppressed with lactic acid but not hydrogen peroxide. BMC Infect. Dis. 11:200
    1. Mossop H, Linhares IM, Zhou X, Bongiovanni AM, Forney L, Ledger WJ, Witkin SS. 2012. Effect of lactic acid on vaginal EMMPRIN production: implications for altered vaginal microbiota-related pathology. Reprod. Sci. 19(Suppl):395A
    1. Braundmeier AG, Dayger CA, Mehrotra P, Belton RJ, Jr, Nowak RA. 2012. EMMPRIN is secreted by human uterine epithelial cells in microvesicles and stimulates metalloproteinase production by human uterine fibroblast cells. Reprod. Sci. 19:1292–1301
    1. Diaz-Cueto L, Cuica-Flores A, Ziga-Cordero F, Ayala-Mendez JA, Tena-Alavez G, Dominguez-Lopez P, Cuevas-Antonio R, Arechavaleta-Velasco F. 2006. Vaginal matrix metalloproteinase levels in pregnant women with bacterial vaginosis. J. Soc. Gynecol. Investig. 13:430–434
    1. Yoon BH, Oh SY, Romero R, Shim SS, Han SY, Park JS, Jun JK. 2001. An elevated amniotic fluid matrix metalloproteinase -8 level at the time of midtrimester genetic amniocentesis is a risk factor for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 185:1162–1167
    1. Larsen B, Goplerud CP, Petzold CR, Ohm-Smith MJ, Galask RP. 1982. Effect of estrogen treatment on the genital tract flora of postmenopausal women. Obstet. Gynecol. 60:20–24
    1. Ginkel PD, Soper DE, Bump RC, Dalton HP. 1993. Vaginal flora in postmenopausal women: the effect of estrogen replacement. Infect. Dis. Obstet. Gynecol. 1:94–97
    1. Alvarez-Olmos MI, Barousse MM, Rajan L, Van Der Pol BJ, Fortenberry D, Orr D, Fidel PL., Jr. 2004. Vaginal lactobacilli in adolescents: presence and relationship to local and systemic immunity, and to bacterial vaginosis. Sex. Transm. Dis. 31:393–400
    1. Noguchi K, Tsukumi K, Udono T, Urano T. 2004. Normal vaginal flora in chimpanzees (Pan troglodytes): qualitative and quantitative study. Comp. Med. 54:705–712
    1. Rivera AJ, Stumpf RM, Wilson B, Leigh S, Salyers AA. 2010. Baboon vaginal microbiota: an overlooked aspect of primate physiology. Am. J. Primatol. 72:467–474
    1. Rivera AJ, Frank JA, Stumpf R, Salyers AA, Wilson BA, Olsen GJ, Leigh S. 2011. Differences between the normal vaginal bacterial community of baboons and that of humans. Am. J. Primatol. 73:119–126
    1. Spear GT, Gilbert D, Sikaroodi M, Doyle L, Green L, Gillevet PM, Landay AL, Veazey RS. 2010. Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res. Hum. Retroviruses 26:193–200
    1. Gajer P, Brotman RM, Bai G, Sakamoto J, Schütte UM, Zhong X, Koenig SSK, Fu L, Ma Z, Zhou X, Abdo Z, Forney LJ, Ravel J. 2012. Dynamics of the human vaginal microbiota. Sci. Transl. Med. 4:ra52
    1. Kim SF, Baek SJ, Pack MY. 1991. Cloning and nucleotide sequence of the Lactobacillus casei lactate dehydrogenase gene. Appl. Environ. Microbiol. 57:2413–2417
    1. Taguchi H, Ohta T. 1991. d-Lactate dehydrogenase is a member of the d-isomer-specific 2-hydroxyacid dehydrogenase family. Cloning, sequencing, and expression in Escherichia coli of the d-lactate dehydrogenase gene of Lactobacillus plantarum. J. Biol. Chem. 266:12588–12594
    1. Gillespie JJ, Wattam AR, Cammer SA, Gabbard JL, Shukla MP, Dalay O, Driscoll T, Hix D, Mane SP, Mao C, Nordberg EK, Scott M, Schulman JR, Snyder EE, Sullivan DE, Wang C, Warren A, Williams KP, Xue T, Yoo HS, Zhang C, Zhang Y, Will R, Kenyon RW, Sobral BW. 2011. Patric: the comprehensive bacterial bioinformatics resource with a focus on human pathogenic species. Infect. Immun. 79:4286–4298

Source: PubMed

3
Abonner